152 related articles for article (PubMed ID: 21926045)
21. Association of autoimmunity and long-term complete remission in patients with Sézary syndrome treated with mogamulizumab.
Bonnet P; Battistella M; Roelens M; Ram-Wolff C; Herms F; Frumholtz L; Bouaziz JD; Brice P; Moins-Teisserenc H; Bagot M; de Masson A
Br J Dermatol; 2019 Feb; 180(2):419-420. PubMed ID: 30328116
[No Abstract] [Full Text] [Related]
22. Subcutaneous alemtuzumab for Sézary Syndrome in the very elderly.
Alinari L; Geskin L; Grady T; Baiocchi RA; Bechtel MA; Porcu P
Leuk Res; 2008 Aug; 32(8):1299-303. PubMed ID: 18096224
[TBL] [Abstract][Full Text] [Related]
23. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome.
Cameron ML; Bartlett JA; Gallis HA; Waskin HA
Rev Infect Dis; 1991; 13(1):64-7. PubMed ID: 2017634
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary infection with Cryptococcus neoformans in the face of underlying sarcoidosis.
Boyton RJ; Altmann DM; Wright A; Kon OM
Respiration; 2007; 74(4):462-6. PubMed ID: 16106116
[TBL] [Abstract][Full Text] [Related]
25. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome.
Lundin J; Hagberg H; Repp R; Cavallin-Ståhl E; Fredén S; Juliusson G; Rosenblad E; Tjønnfjord G; Wiklund T; Osterborg A
Blood; 2003 Jun; 101(11):4267-72. PubMed ID: 12543862
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary cryptocococcis followed by pulmonary tuberculosis. A case report.
Riley E; Cahan WG
Am Rev Respir Dis; 1972 Oct; 106(4):594-9. PubMed ID: 4627831
[No Abstract] [Full Text] [Related]
27. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
28. Case records of the Massachusetts General Hospital. Case 24-2013. A 53-year-old woman with erythroderma, pruritus, and lymphadenopathy.
Carter JB; Barnes JA; Niell BL; Nardi V
N Engl J Med; 2013 Aug; 369(6):559-69. PubMed ID: 23924007
[No Abstract] [Full Text] [Related]
29. Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody).
Osborne GE; Pagliuca A; Ho A; du Vivier AW
Br J Dermatol; 2006 Sep; 155(3):617-20. PubMed ID: 16911291
[TBL] [Abstract][Full Text] [Related]
30. Hypoglycemia in a patient with advanced Sezary syndrome.
Anagnostis P; Vakalopoulou S; Slavakis A; Simoulidou E; Rakitzi P; Garipidou V; Harsoulis F
Leuk Lymphoma; 2009 Feb; 50(2):284-6. PubMed ID: 19160123
[No Abstract] [Full Text] [Related]
31. State of the art therapy of mycosis fungoides and Sézary syndrome.
Kemme DJ; Bunn PA
Oncology (Williston Park); 1992 Feb; 6(2):31-42; discussion 44, 47-8. PubMed ID: 1532501
[TBL] [Abstract][Full Text] [Related]
32. Bexarotene monotherapy for patients with refractory Sézary syndrome.
Staib G; Scharffetter-Kochanek K
Dermatol Clin; 2008 Jan; 26 Suppl 1():61-3. PubMed ID: 18405190
[No Abstract] [Full Text] [Related]
33. Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab.
Ricci C; Pileri A; Agostinelli C; Ambrosi F; Zinzani PL; Sabattini E
J Dtsch Dermatol Ges; 2018 Oct; 16(10):1263-1265. PubMed ID: 30277017
[No Abstract] [Full Text] [Related]
34. Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy.
Vaughan J; Harrington AM; Hari PN; Kroft SH; Olteanu H
Am J Clin Pathol; 2012 Mar; 137(3):403-11. PubMed ID: 22338052
[TBL] [Abstract][Full Text] [Related]
35. Mutation in PIGA results in a CD52-negative escape variant in a Sézary syndrome patient during alemtuzumab treatment.
Halkes CJM; Zoutman WH; van der Fits L; Jedema I; Vermeer MH
J Invest Dermatol; 2015 Apr; 135(4):1199-1202. PubMed ID: 25431852
[No Abstract] [Full Text] [Related]
36. Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab.
Nosari A; Tedeschi A; Ricci F; Montillo M
Haematologica; 2008 Feb; 93(2):e30-1. PubMed ID: 18245646
[TBL] [Abstract][Full Text] [Related]
37. Successful renal allograft in a patient with pulmonary cryptococcus.
Swenson RS; Kountz SL; Blank N; Merigan TC
Arch Intern Med; 1969 Oct; 124(4):502-6. PubMed ID: 4898545
[No Abstract] [Full Text] [Related]
38. Treatment of Sézary syndrome with bexarotene after IFNalpha and methotrexate failure.
Bagot M
Dermatol Clin; 2008 Jan; 26 Suppl 1():27-9. PubMed ID: 18405184
[No Abstract] [Full Text] [Related]
39. Endobronchial pulmonary cryptococcosis and tuberculosis in an immunocompetent host.
Thomas R; Christopher DJ; Balamugesh T; James P; Thomas M
Singapore Med J; 2012 Feb; 53(2):e32-4. PubMed ID: 22337198
[TBL] [Abstract][Full Text] [Related]
40. [16 cases of infection by Cryptococcosis neoformans in patients with AIDS].
Castro Guardiola A; Ocaña Rivera I; Gasser Laguna I; Ruiz Camps I; Planes Reig AM; Juste Sánchez C; Martínez Vázquez JM
Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):90-4. PubMed ID: 1854856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
